Emma Dernelley
About Emma Dernelley
Emma Dernelley is the Country Quality Lead for Australia and New Zealand at BeiGene, with over 25 years of experience in the biotechnology and pharmaceutical industry.
Current Role at BeiGene
Emma Dernelley currently serves as the Country Quality Lead for Australia and New Zealand at BeiGene. She is based in Melbourne, Victoria, Australia, and has been with BeiGene since November 2020. In this role, she oversees quality initiatives and ensures compliance with regulatory requirements in the biotechnology field.
Previous Roles at Amgen
Emma Dernelley has a rich history with Amgen, spanning multiple roles over 26 years. From 2012 to 2020, she served as the Senior Quality Manager for Australia and New Zealand within the JAPAC region. Prior to this, from 2004 to 2012, she was the Executive Biopharmaceutical Sales Manager specializing in Nephrology. From 2000 to 2004, she held the position of Regulatory Compliance Manager, and from 1994 to 2000, she was a Sales Support Business Analyst.
Educational Background
Emma Dernelley holds a Bachelor's degree in Business Administration and Management, which she earned from Swinburne University of Technology between 2000 and 2004. She also studied at The University of Queensland. Her educational background has equipped her with a comprehensive understanding of business administration and management practices.
Experience in Biotechnology and Pharmaceuticals
Emma Dernelley boasts over 25 years of experience in the biotechnology and pharmaceutical industry. Her career commenced in 1994, and she has since specialized in Quality Management, Good Distribution Practice (GDP), and Change Control. Her extensive experience positions her as a knowledgeable leader in the field, capable of managing complex regulatory and quality requirements.
Specializations in Quality Management
Throughout her career, Emma Dernelley has specialized in quality management, focusing specifically on Good Distribution Practice (GDP) and Change Control. Her commitment to these areas has enabled her to effectively oversee and enhance quality measures and regulatory compliance in the companies she has worked for, including her current role at BeiGene and her previous extensive tenure at Amgen.